Chengdu Bright Eye Hospital Co. Ltd. (301239) - Total Assets
Based on the latest financial reports, Chengdu Bright Eye Hospital Co. Ltd. (301239) holds total assets worth CN¥4.74 Billion CNY (≈ $694.16 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Chengdu Bright Eye Hospital Co. Ltd. - Total Assets Trend (2019–2025)
This chart illustrates how Chengdu Bright Eye Hospital Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. Also see how much is Chengdu Bright Eye Hospital Co. Ltd. worth for the company's overall valuation and market capitalisation.
Chengdu Bright Eye Hospital Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2025)
Chengdu Bright Eye Hospital Co. Ltd.'s total assets of CN¥4.74 Billion consist of 18.8% current assets and 81.2% non-current assets. Review Chengdu Bright Eye Hospital Co. Ltd. total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.5% |
| Accounts Receivable | CN¥97.19 Million | 2.1% |
| Inventory | CN¥202.64 Million | 4.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥42.45 Million | 0.9% |
| Goodwill | CN¥411.90 Million | 9.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Chengdu Bright Eye Hospital Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 301239 stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Chengdu Bright Eye Hospital Co. Ltd.'s current assets represent 18.8% of total assets in 2025, a decrease from 40.7% in 2019.
- Cash Position: Cash and equivalents constituted 7.5% of total assets in 2025, down from 21.6% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 4.0% in 2019.
- Asset Diversification: The largest asset category is goodwill at 9.0% of total assets.
Chengdu Bright Eye Hospital Co. Ltd. Competitors by Total Assets
Key competitors of Chengdu Bright Eye Hospital Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Surgery Partners Inc
NASDAQ:SGRY
|
USA | $7.95 Billion |
|
agilon health Inc
NYSE:AGL
|
USA | $1.59 Billion |
|
Pacific Smiles Group Ltd
AU:PSQ
|
Australia | AU$163.53 Million |
|
Eifelhöhen-Klinik AG
F:EIF
|
Germany | €36.20 Million |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
|
Regis Healthcare Ltd
AU:REG
|
Australia | AU$2.11 Billion |
|
Oceania Healthcare Ltd
AU:OCA
|
Australia | AU$3.01 Billion |
|
Rede D'Or São Luiz S.A.
SA:RDOR3
|
Brazil | R$110.03 Billion |
Chengdu Bright Eye Hospital Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 1.14 | 0.66 |
| Quick Ratio | 0.91 | 0.96 | 0.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥145.54 Million | CN¥126.60 Million | CN¥-192.44 Million |
Chengdu Bright Eye Hospital Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Chengdu Bright Eye Hospital Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.69 |
| Latest Market Cap to Assets Ratio | 0.15 |
| Asset Growth Rate (YoY) | -0.9% |
| Total Assets | CN¥4.56 Billion |
| Market Capitalization | $684.62 Million USD |
Valuation Analysis
Below Book Valuation: The market values Chengdu Bright Eye Hospital Co. Ltd.'s assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Chengdu Bright Eye Hospital Co. Ltd.'s assets decreased by 0.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Chengdu Bright Eye Hospital Co. Ltd. (2019–2025)
The table below shows the annual total assets of Chengdu Bright Eye Hospital Co. Ltd. from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.56 Billion ≈ $666.65 Million |
-0.92% |
| 2024-12-31 | CN¥4.60 Billion ≈ $672.84 Million |
-4.51% |
| 2023-12-31 | CN¥4.82 Billion ≈ $704.59 Million |
+30.95% |
| 2022-12-31 | CN¥3.68 Billion ≈ $538.06 Million |
+58.11% |
| 2021-12-31 | CN¥2.33 Billion ≈ $340.31 Million |
+12.00% |
| 2020-12-31 | CN¥2.08 Billion ≈ $303.85 Million |
+112.48% |
| 2019-12-31 | CN¥977.22 Million ≈ $143.00 Million |
-- |
About Chengdu Bright Eye Hospital Co. Ltd.
Bright Eye Hospital Group Co., Ltd., together with its subsidiaries, operates ophthalmic medical institutions in China. The company offers ophthalmic diagnostic and treatment services, including refractive surgery, medical optometry and glasses fitting, cataract surgery, glaucoma treatment, strabismus and amblyopia, pediatric ophthalmology, fundus diseases treatment, oculoplastic surgery, lacrima… Read more